Departement of Surgery, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, 1091 AC, Amsterdam, The Netherlands.
J Gastrointest Surg. 2009 Oct;13(10):1839-44. doi: 10.1007/s11605-009-0970-z. Epub 2009 Jul 28.
Selective decontamination of the digestive tract (SDD) decreases morbidity and mortality in critically ill patients and morbidity in patients undergoing esophageal resection. This study analyzes the effect of perioperative SDD in patients undergoing elective colorectal surgery on postoperative infections and anastomotic leakage.
This is a retrospective analysis of prospectively collected data in a 3-year cohort of 162 patients undergoing elective resection of colon and or rectum. Of these patients, 76 (47%) received SDD (polymyxine B sulfate, tobramycin, and amphotericin) perioperatively. The control group consisted of 86 patients who were not treated with SDD. Postoperative complications, hospital stay, and mortality were analyzed.
In the SDD group, there were six patients (7.9%) with infectious complications compared with 17 patients (19.8%) in the control group (p = 0.031). The incidence of the combined endpoint infectious complications and anastomotic leakage was 8 (11%) in the SDD group vs. 22 (26%) in the control group (p = 0.014). Multivariate analysis showed that no-SDD, aged above 60 years and diabetes were independent predictors of postoperative complications.
Perioperative SDD in elective colorectal surgery seems to reduce postoperative surgical complications including infectious complications and anastomotic leakage. Prospective, randomized, placebo-controlled studies are needed to confirm this conclusion.
消化道选择性去污染(SDD)可降低危重症患者的发病率和死亡率,并降低接受食管切除术患者的发病率。本研究分析了选择性结直肠手术围手术期 SDD 对术后感染和吻合口漏的影响。
这是一项对 162 例接受择期结肠和直肠切除术的患者前瞻性收集数据进行的回顾性分析。其中 76 例(47%)患者围手术期接受 SDD(硫酸多粘菌素 B、妥布霉素和两性霉素)治疗。对照组由 86 例未接受 SDD 治疗的患者组成。分析术后并发症、住院时间和死亡率。
在 SDD 组中,有 6 例(7.9%)患者发生感染性并发症,而对照组有 17 例(19.8%)(p = 0.031)。SDD 组感染性并发症和吻合口漏的复合终点发生率为 8 例(11%),对照组为 22 例(26%)(p = 0.014)。多变量分析显示,非 SDD、年龄大于 60 岁和糖尿病是术后并发症的独立预测因素。
择期结直肠手术围手术期 SDD 似乎可降低术后手术并发症,包括感染性并发症和吻合口漏。需要前瞻性、随机、安慰剂对照研究来证实这一结论。